The current study first outlines that PD-1 blockade has an antitumor function in HNSCC, at least partially, dependent on the role of CD47/SIRPα which functions as a “do not eat me” signal in many malignancies. The gene discussed is CD47; the disease is head and neck squamous cell carcinoma.